Andexanet alfa, sold under the brand name Andexxa among others, is an antidote for the medications rivaroxaban and apixaban, when reversal of anticoagulation...
14 KB (1,177 words) - 04:30, 31 March 2024
asfotase alfa (Strensiq), used to treat hypophosphatasia; sebelipase alfa (Kanuma), used to treat lysosomal acid lipase deficiency, and andexanet alfa (Andexxa)...
20 KB (1,377 words) - 17:48, 12 March 2024
reuptake inhibitors, and nonsteroidal anti-inflammatory drugs (NSAIDs). Andexanet alfa is a US Food and Drug Administration (FDA) approved antidote for apixaban...
23 KB (1,889 words) - 02:56, 7 March 2024
DOACs are not as widely studied, idarucizumab (for dabigatran) and andexanet alfa (for factor Xa inhibitor) have been used in clinical settings with varying...
78 KB (8,726 words) - 15:18, 29 April 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
21 KB (2,196 words) - 21:28, 13 April 2024
trials for andexanet alfa as an antidote for Factor Xa inhibitors with few adverse effects, and started Phase III trials. Andexanet alfa was approved...
30 KB (2,709 words) - 04:35, 20 May 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
18 KB (1,654 words) - 03:05, 18 May 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
31 KB (2,754 words) - 05:58, 1 April 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
24 KB (1,905 words) - 05:58, 10 March 2024
v t e AstraZeneca Products Acalabrutinib Anastrozole Andexanet alfa Anifrolumab Asfotase alfa Atenolol Benralizumab Bicalutamide Brompheniramine Budesonide...
10 KB (703 words) - 17:18, 20 April 2024